M1201 HCPCS Reimbursement & Policy Benchmarks | OpenPayer

Summary & Overview

HCPCS M1201: Documentation of Medical Reason for Not Prescribing ACE-i/ARB Therapy

HCPCS Level II code M1201 records documented medical reasons for not prescribing ACE inhibitor (ACE-i) or angiotensin receptor blocker (ARB) therapy during an accountability period. This code captures clinically important exceptions such as pregnancy, prior angioedema with ACE-i, documented allergies to ACE-i or ARB, hyperkalemia or prior hyperkalemia while on therapy, acute kidney injury attributed to these agents, and other medical contraindications. Nationally, standardized documentation of therapeutic exceptions supports quality measurement accuracy and appropriate performance reporting.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for the code, the service setting where the code is typically used, and the types of documentation that underpin its application. The report also outlines benchmarking and policy-relevant considerations such as implications for quality measures, claims processing, and audit readiness. Where available, the publication highlights common modifiers and administrative considerations for claim submission; if specific payer guidance or diagnosis linkages are not provided in the input, those items are noted as not available.

This summary is intended for national audiences involved in coding, compliance, quality measurement, and clinical documentation improvement, offering a clear reference to the purpose and use of HCPCS Level II code M1201 without making clinical recommendations.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareM1201HCPCS Level IIACE inhibitorARBclinical documentationquality measurementmedication exceptionsoutpatient care

Billing Code Overview

HCPCS Level II code M1201 documents the medical reason(s) for not prescribing angiotensin-converting enzyme inhibitor (ACE-i) or angiotensin receptor blocker (ARB) therapy during the measurement period. Examples include pregnancy, history of angioedema to ACE-i, other allergy to ACE-i and ARB, hyperkalemia or history of hyperkalemia while on ACE-i or ARB therapy, acute kidney injury due to ACE-i or ARB therapy, and other documented medical reasons.

Service type: Clinical documentation of medical contraindication or medical reason for omission of ACE-i/ARB therapy.

Typical site of service: Outpatient clinical settings where chronic disease management and medication reconciliation occur, such as primary care offices, cardiology clinics, nephrology clinics, and ambulatory care locations.

Clinical & Coding Specifications

Clinical Context

A 58-year-old patient with chronic systolic heart failure and hypertension attends a primary care visit for medication reconciliation and quality-measure documentation. The clinician reviews the medication list and history, and documents that the patient is not prescribed an angiotensin-converting enzyme inhibitor (ACE-i) or angiotensin II receptor blocker (ARB) during the measurement period because of a prior episode of angioedema attributed to an ACE inhibitor and a documented serum potassium level persistently above 5.5 mEq/L while previously treated with ARB therapy. The clinician records the medical reasons in the problem list and clinical note, cites laboratory and prior hospitalization records, and assigns the HCPCS Level II billable reason code M1201 to indicate medical justification for non-prescription of ACE-i/ARB.

Typical workflow: the patient encounter takes place in an ambulatory primary care clinic or cardiology outpatient clinic. The provider reviews charted allergies, prior adverse reactions, and recent laboratory values. If a contraindication or adverse event is present, the provider documents the specific medical reason(s) for not prescribing ACE-i/ARB (e.g., pregnancy, angioedema, hyperkalemia, acute kidney injury), references supporting evidence (labs, prior notes), and codes M1201 on the encounter. Nursing staff may obtain vitals and labs; pharmacy or specialty notes may be attached. This documentation supports quality reporting and payer adjudication.

Coding Specifications

Modifier	Description	When to Use

HCPCS M1393: Nonrecurrent Melanoma Status

HCPCS-M1392-DOCUMENTATION-NO-EXAMINATION-REFUSAL-LOST-FOLLOW-UP

HCPCS M1392: Documentation of No Examination (Refusal or Lost to Follow-up)

HCPCS-M1418-COVID19-VACCINATION-MEDICAL-CONTRAINDICATION

HCPCS M1418: COVID-19 Vaccination Not Up to Date Due to Medical Contraindication

HCPCS-M1281-BLOOD-PRESSURE-NOT-DOCUMENTED

HCPCS Level II M1281: Blood Pressure Not Documented, Reason Not Given

HCPCS-M1448-PERSONALITY-DISORDER-DIAGNOSIS-MEASURE

HCPCS M1448: Personality Disorder Diagnosis for Measurement

HCPCS-M1240-PATIENT-NO-RESPONSE-PROVIDER-BEST-INTERESTS-QUESTION

HCPCS M1240: Patient Nonresponse to Provider Best-Interests Question

HCPCS-M1499-INTERVENTIONAL-RADIOLOGY-MIPS-VALUE-PATHWAY

HCPCS Level II M1499: Interventional Radiology MIPS Value Pathway

HCPCS-M1442-TELEHEALTH-ENCOUNTER-VISIT-VIRTUAL-CARE

HCPCS Level II M1442: Telehealth Encounter / Virtual Visit

HCPCS-M1469-HEPATITIS-B-HISTORY-OR-POSITIVE-HEPATITIS-B-TEST

HCPCS Level II M1469: Hepatitis B History or Positive Hepatitis B Test

HCPCS-M1149-NECK-PROM-UNABLE-TO-COMPLETE-DUE-TO-BARRIERS

HCPCS M1149: Neck PROM Not Completed Due to Patient Barriers

Showing 1–10 of 356

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Commonly documents chronic medication decisions and contraindications in primary care.
`207R00000X`	Internal Medicine	Frequently provides chronic disease management and documents reasons for non-prescription of ACE-i/ARB.
`207RL0500X`	Cardiology	Cardiologists document contraindications related to heart failure or angioedema histories.
`363L00000X`	Nurse Practitioner	NPs in ambulatory settings commonly perform medication reconciliation and document `M1201` reasons.
`246Q00000X`	Physician Assistant	PAs in outpatient clinics document medication contraindications and rationale supporting `M1201`.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I50.22`	Chronic systolic (congestive) heart failure	Heart failure is a common indication for ACE-i/ARB; documentation of medical reasons for non-use is relevant when therapy is withheld.
`I12.9`	Hypertensive chronic kidney disease with stage unspecified chronic kidney disease and hypertension	Renal dysfunction can contraindicate ACE-i/ARB or require close monitoring; used when kidney disease explains non-prescription.
`T78.3XXA`	Angioneurotic edema, initial encounter	Prior angioedema to ACE-i is a contraindication and a common documented reason for non-prescription coded with `M1201`.
`O09.59`	Supervision of pregnancy with other multiple gestation, third trimester	Pregnancy and potential teratogenic risk are indications to avoid ACE-i/ARB; obstetric contexts require documentation.
`E87.5`	Hyperkalemia	Elevated serum potassium is a direct medical reason to withhold ACE-i/ARB and should be documented to support `M1201`.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for the visit during which documentation for `M1201` is completed.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes	Used when more complex medical decision making and documentation are required to justify non-prescription of ACE-i/ARB.
`36415`	Collection of venous blood by venipuncture	Often performed to obtain laboratory tests (serum potassium, creatinine) that support the medical reason for withholding ACE-i/ARB.
`85025`	Complete blood count (CBC) automated; 1992 (single WBC diff)	May be part of routine labs ordered during the encounter but not directly related to `M1201` justification.
`82565`	Creatinine; serum	Relevant laboratory test to document renal function when assessing acute kidney injury or chronic kidney disease as a reason to avoid ACE-i/ARB.
`84132`	Potassium; serum	Directly used to document hyperkalemia as a contraindication supporting `M1201`.

OpenPayer